Evidence map›Paper›PMID 9860984›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

Metabolism to a response pathway selective retinoid ligand during axial pattern formation.

W W Pijnappel, G E Folkers, W J de Jonge, P J Verdegem, S W de Laat, J Lugtenburg, H F Hendriks, P T van der Saag, A J Durston

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Carotenoid modifying enzymes in metazoans.Methods in enzymology · 2022
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

W W PijnappelHubrecht Laboratory, Netherlands Institute for Developmental Biology, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands.
G E Folkers
W J de Jonge
P J Verdegem
S W de Laat
J Lugtenburg
H F Hendriks
P T van der Saag
A J Durston
Hubrecht Institute for Developmental Biology and Stem Cell Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report identification of 9-cis-4-oxo-retinoic acid (9-cis-4-oxo-RA) as an in vivo retinoid metabolite in Xenopus embryos. 9-Cis-4-oxo-RA bound receptors (RARs) alpha, beta, and gamma as well as retinoid X receptors (RXRs) alpha, beta, and gamma in vitro. However, this retinoid displayed differential RXR activation depending on the response pathway used. Although it failed to activate RXRs in RXR homodimers, it activated RXRs and RARs synergistically in RAR-RXR heterodimers. 9-Cis-4-oxo-RA thus acted as a dimer-specific agonist. Considering that RAR-RXR heterodimers are major functional units involved in transducing retinoid signals during embryogenesis and that 9-cis-4-oxo-RA displayed high potency for modulating axial pattern formation in Xenopus, metabolism to 9-cis-4-oxo-RA may provide a mechanism to target retinoid action to this and other RAR-RXR heterodimer-mediated processes.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsBody PatterningDimerizationKineticsReceptors, Retinoic AcidRecombinant Fusion ProteinsRetinoic Acid Receptor alphaRetinoic Acid Receptor gammaRetinoidsRetinoid X ReceptorsTranscription FactorsXenopusReceptors, Retinoic AcidRecombinant Fusion ProteinsRetinoic Acid Receptor alpharetinoic acid receptor betaRetinoic Acid Receptor gammaRetinoidsRetinoid X ReceptorsTranscription Factors

Identifiers

PMID9860984
PMCPMC28058
OpenAlexW2078808189

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.